Advancing Schizophrenia Management Strategies in the Patient Journey: Treatment Innovations, Adherence, and Health Outcomes

Overview

Pricing: Free for Members and Non-Members

Course Description

Considering the complexities of managing schizophrenia in the United States, this session addresses the disease of schizophrenia from the patient, clinical expert, and managed care pharmacist perspective.

A comprehensive review of the clinical aspects of schizophrenia, focusing on its prevalence, diagnosis, progression, complications, and treatment challenges, will be provided, as well as the managed care strategies essential for improving access, adherence, and health outcomes for individuals with schizophrenia. Faculty will emphasize the unique challenges faced by at-risk populations, particularly within diverse and underserved communities, and explore the economic impact of treatment-resistant and poorly controlled schizophrenia.

Keeping the patient at the forefront, the audience will hear from a patient who will describe her journey leading to diagnosis and treatment and address the disease burden, factors influencing adherence and quality of life considerations related to treatment.

View Bethany's Patient Story: Schizophrenia

In this video, Bethany from Ohio shares her health journey with schizophrenia and depression, and side effects from going off her medication. She spent a year trying different anti-psychotic medications. "I needed to learn that it was actually a chemical imbalance. I didn't understand that this medication would actually heal the tissue of my brain, and I had no idea that a medication could help you live a better life... Doctors should never give up on their patients."

Target Audience

Pharmacists who practice in managed care settings.

Learning Objectives

At the completion of this activity, participants should be able to:

  1. Describe the lived experience of patients with schizophrenia, including factors that impact medication adherence and quality of life.
  2. Distinguish the new and emerging therapies for schizophrenia, including clinical efficacy, safety, and adherence considerations.
  3. Discuss managed care opportunities to support patients with schizophrenia to improve adherence, and health outcomes.

Commercial Support

This activity is supported by an independent medical education grant from Bristol Myers Squibb.

Course summary
Available credit: 
  • 1.25 ACPE
    ACPE The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
  • 1.25 Certificate of Completion
Course opens: 
01/30/2025
Course expires: 
12/31/2025
Cost:
$0.00

Program

Faculty

Catherine Cooke, PharmD, MS, BCPS, PAHM

Research Associate Professor
University of Maryland School of Pharmacy
Baltimore, MD

Megan Ehret, PharmD, MS, BCPP

Professor and Co-Director Mental Health Program
University of Maryland, School of Pharmacy
Monrovia, MD

Bethany Yeiser, BS

President
The CURESZ Foundation
Fairfield, OH

Disclosures

Faculty/Reviewer/Planner​

Reported Relevant Financial Relationships​

Megan Ehret, PharmD, MS, BCPP​

Faculty​

Consultant: Saladex Biomedical, LLC. ​

Bethany Yeiser, BS​

Faculty​

Faculty/Speaker: Bristol Meyers Squibb, TEVA Pharmaceuticals​

Reviewer: Alkermes, Boehringer Ingelheim, Janssen​

Catherine E. Cooke, PharmD, MS, BCPS, PAHM​

Faculty​

No relevant financial relationships.​

Tracy McDowd, PharmD, FAMCP ​

Peer Reviewer​

Disclosed no relevant financial relationships.​

Teresa Roane, PharmD, MBA, BCACP, CPH​

Peer Reviewer​

Disclosed no relevant financial relationships.​

Angela Cassano, PharmD, BCPS, FASHP​

Planner​

Disclosed no relevant financial relationships.​

Brittany V. Henry, PharmD, MBA​

Planner​

Disclosed no relevant financial relationships.​

Accreditation

The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

ACPE UAN: 0233-0000-24-059-H01-P • Activity Type: Knowledge-Based
Contact Hours: 1.25
Release Date: January 30, 2024 •  Expiration Date: December 31, 2025
Activity Fee: Free for Members and Non-Members

Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at Nexus 2024. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.

To receive credit for an online activity you must:

  • Review the full content of the activity.
  • Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
  • Complete a specific activity evaluation.

Available Credit

  • 1.25 ACPE
    ACPE The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
  • 1.25 Certificate of Completion

Register/Take course

Price

Cost:
$0.00
Please login or register to take this course.